Transfusion Strategy in Myocardial Infarction and Anemia | NEJM
Correspondence from The New England Journal of Medicine — Transfusion Strategy in Myocardial Infarction and Anemia
Correspondence from The New England Journal of Medicine — Transfusion Strategy in Myocardial Infarction and Anemia
Welcome to DAS-CAM: EHRA Level 3 – Leadership and Innovation in Cardiac Arrhythmia Management.
Abdominal pain and large-volume hematochezia developed in a man who was in the hospital for a ruptured cerebral aneurysm. Findings on endoscopy and colonoscopy were…
The NorthShore Cardiovascular Institute provides quality and compassionate cardiac and vascular care. Learn more about how we deliver the highest level of care.
Listen to this episode from CardioSpaces on Spotify. En este #CardioSpace hablaremos sobre cómo se aborda el riesgo cardiovascular desde distintos puntos de vista. Para…
April 30, 2024 — The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular disease in adult cardiac patients, with…
April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a…
April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk…
AcuteCVDays, brought to you by the Association for Acute Cardiovascular Care (ACVC), facilitates learning and discussing potential differences between North America and Europe in the…
This editorial refers to ‘Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization’, by M. Takahara et a
The study may decrease the use of implantable cardioverter defibrillators (ICD), as advances in medical therapies have improved outcomes for patients with heart failure.